The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
{{output}}
Non-alcoholic fatty liver disease (NAFLD) is a multifaceted metabolic disorder, whose spectrum covers clinical, histological and pathophysiological developments ranging from simple steatosis to non-alcoholic steatohepatitis (NASH) and liver fibrosis, potential... ...
